Eurofins Central Laboratory is a global organization fully focused and dedicated to providing standardized, high quality global central laboratory services to support all phases of clinical trials. Eurofins Central Laboratory supports its customers with 4 wholly-owned and harmonized laboratory facilities located in the US, Europe, Singapore and China. With 25+ years of experience and scientific accomplishment, its laboratory testing portfolio has become one of the widest available in the biopharmaceutical industry and offers the synergy of integrated safety assessment, exploratory biomarkers, end point biomarkers, biomarker development, therapeutic drug monitoring, genomic testing and a full range of services to support vaccine development. Eurofins Central Laboratory provides the highest quality central laboratory services, accurate, timely results capturing the planned completion date, and expert advice from their highly qualified team of experienced scientists.